Insulet Corporation stock is up 20.18% since 30 days ago. The next earnings date is Feb 22, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 47.06% of the previous 16 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
27 Nov 16:49 | 15 Dec, 2023 | 170.00 | 378 | ||
27 Nov 20:14 | 15 Mar, 2024 | 170.00 | 138 | ||
29 Nov 15:13 | 15 Dec, 2023 | 200.00 | 605 | ||
29 Nov 16:45 | 19 Jan, 2024 | 195.00 | 52 | ||
29 Nov 16:48 | 19 Jan, 2024 | 195.00 | 52 | ||
29 Nov 19:37 | 15 Dec, 2023 | 200.00 | 605 | ||
30 Nov 18:37 | 21 Jun, 2024 | 190.00 | 103 | ||
01 Dec 17:56 | 15 Mar, 2024 | 185.00 | 23 | ||
04 Dec 14:38 | 19 Jan, 2024 | 220.00 | 101 | ||
06 Dec 18:45 | 20 Dec, 2024 | 260.00 | 2 |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless device that is worn on the body for up to three days at a time. The company sells its products primarily through independent distributors and pharmacy channels.